Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) had its price objective boosted by analysts at Mizuho from $21.00 to $22.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a "neutral" rating on the real estate investment trust's stock. Mizuho's price target would suggest a potential upside of 7.33% from the stock's previous close.
Other equities analysts have also recently issued reports about the stock. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a "buy" rating in a research note on Wednesday, July 22nd. Citizens Jmp increased their target price on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a "market outperform" rating in a report on Wednesday, July 22nd. Robert W. Baird increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Monday, August 31st. Deutsche Bank restated a "buy" rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Finally, UBS Group lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Wednesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $21.92.
Get Our Latest Research Report on Sabra Healthcare REIT
Sabra Healthcare REIT Trading Up 0.3%
SBRA traded up $0.06 on Monday, hitting $20.50. The company had a trading volume of 390,340 shares, compared to its average volume of 2,677,219. The firm has a market cap of $5.37 billion, a P/E ratio of 73.20, a PEG ratio of 1.78 and a beta of 0.68. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.86. Sabra Healthcare REIT has a 1 year low of $17.53 and a 1 year high of $22.77. The company's fifty day moving average price is $19.88 and its 200 day moving average price is $20.04.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.05). The business had revenue of $249.57 million during the quarter, compared to analysts' expectations of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The business's quarterly revenue was up 31.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.38 EPS. As a group, equities analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.
Insiders Place Their Bets
In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the firm's stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company's stock, valued at $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael Foster sold 10,000 shares of the company's stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the sale, the director directly owned 72,834 shares of the company's stock, valued at $1,528,057.32. The trade was a 12.07% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.09% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Sabra Healthcare REIT
A number of institutional investors have recently added to or reduced their stakes in SBRA. Lasalle Investment Management Securities LLC lifted its stake in Sabra Healthcare REIT by 8.2% in the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust's stock valued at $73,547,000 after acquiring an additional 290,405 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust's stock worth $71,640,000 after acquiring an additional 269,793 shares during the period. Russell Investments Group Ltd. grew its position in shares of Sabra Healthcare REIT by 70.2% in the third quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust's stock valued at $36,615,000 after purchasing an additional 765,527 shares during the last quarter. Rush Island Management LP acquired a new stake in shares of Sabra Healthcare REIT in the first quarter worth $30,735,000. Finally, Sound Income Strategies LLC lifted its stake in shares of Sabra Healthcare REIT by 8.3% in the third quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust's stock valued at $19,815,000 after buying an additional 80,453 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.
Sabra Healthcare REIT Company Profile
(
Get Free Report)
Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company's properties are located in the United States and Canada.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.